Longlasting remissions after treatment with rituximab for autoimmune myositis

J Rheumatol. 2008 Jun;35(6):1230-2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / administration & dosage*
  • Dermatomyositis / drug therapy*
  • Drug Administration Schedule
  • Humans
  • Male
  • Middle Aged
  • Paraneoplastic Syndromes / drug therapy*
  • Rituximab
  • Time
  • Treatment Failure

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab